{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:41:50Z","timestamp":1791438110789,"version":"4.3.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-227x-9-5","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T06:28:10Z","timestamp":1240986490000},"source":"Crossref","is-referenced-by-count":59,"title":["Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse\/toxicology screening in emergency medicine"],"prefix":"10.1186","volume":"9","author":[{"given":"Matthew D","family":"Krasowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F","family":"Pizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G","family":"Siam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Giannoutsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"74_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/pds.1351","volume":"16","author":"ML Becker","year":"2007","unstructured":"Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH: Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007, 16: 641-651. 10.1002\/pds.1351.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"74_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.emc.2006.06.008","volume":"24","author":"G D'Onofrio","year":"2006","unstructured":"D'Onofrio G, Becker B, Woolard RH: The impact of alcohol, tobacco, and other drug use and abuse in the emergency department. Emerg Med Clin North Am. 2006, 24: 925-967. 10.1016\/j.emc.2006.06.008.","journal-title":"Emerg Med Clin North Am"},{"key":"74_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1373\/49.3.357","volume":"49","author":"AHB Wu","year":"2003","unstructured":"Wu AHB, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003, 49: 357-379. 10.1373\/49.3.357.","journal-title":"Clin Chem"},{"key":"74_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.168.14.1561","volume":"168","author":"DP Phillips","year":"2008","unstructured":"Phillips DP, Barker GE, Eguchi MM: A steep increase in the domestic fatal medication errors with use of alcohol and\/or street drugs. Arch Intern Med. 2008, 168: 1561-1566. 10.1001\/archinte.168.14.1561.","journal-title":"Arch Intern Med"},{"key":"74_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","volume":"315","author":"CA Hammett-Stabler","year":"2002","unstructured":"Hammett-Stabler CA, Pesce AJ, Cannon DJ: Urine drug screening in the medical setting. Clin Chim Acta. 2002, 315: 125-135. 10.1016\/S0009-8981(01)00714-8.","journal-title":"Clin Chim Acta"},{"key":"74_CR6","first-page":"219","volume-title":"Tietz textbook of clinical chemistry and molecular diagnostics","author":"LJ Kricka","year":"2006","unstructured":"Kricka LJ: Principles of immunochemical techniques. Tietz textbook of clinical chemistry and molecular diagnostics. Edited by: Burtis CA, Ashwood ER, Bruns DE. 2006, St. Louis, MO: Elsevier Saunders, 219-243. 4","edition":"4"},{"key":"74_CR7","first-page":"1287","volume-title":"Tietz textbook of clinical chemistry and molecular diagnostics","author":"WH Porter","year":"2006","unstructured":"Porter WH: Clinical toxicology. Tietz textbook of clinical chemistry and molecular diagnostics. Edited by: Burtis CA, Ashwood ER, Bruns DE. 2006, St. Louis, MO: Elsevier Saunders, 1287-1369."},{"key":"74_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/clinchem\/20.2.243","volume":"20","author":"SJ Mul\u00e9","year":"1974","unstructured":"Mul\u00e9 SJ, Bastos ML, Jukofsky D: Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse. Clin Chem. 1974, 20: 243-248.","journal-title":"Clin Chem"},{"key":"74_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.174.4013.1036","volume":"174","author":"S Spector","year":"1971","unstructured":"Spector S, Flynn EJ: Barbiturates: radioimmunoassay. Science. 1971, 174: 1036-1038. 10.1126\/science.174.4013.1036.","journal-title":"Science"},{"key":"74_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4065\/83.1.66","volume":"83","author":"KE Moeller","year":"2008","unstructured":"Moeller KE, Lee KC, Kissack JC: Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008, 83: 66-76. 10.4065\/83.1.66.","journal-title":"Mayo Clin Proc"},{"key":"74_CR11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/clinchem\/46.8.1037","volume":"46","author":"LJ Kricka","year":"2000","unstructured":"Kricka LJ: Interferences in immunoassays \u2013 still a threat. Clin Chem. 2000, 46: 1037-1038.","journal-title":"Clin Chem"},{"key":"74_CR12","volume-title":"Interference testing in clinical chemistry (EP7-A)","author":"DM Powers","year":"1986","unstructured":"Powers DM, Boyd JC, Glick MR: Interference testing in clinical chemistry (EP7-A). 1986, Villanova, PA: NCCLS"},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1001\/jama.286.24.3115","volume":"286","author":"LR Baden","year":"2001","unstructured":"Baden LR, Horowitz G, Jacoby H, Eliopoulos GM: Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA. 2001, 286: 3115-3119. 10.1001\/jama.286.24.3115.","journal-title":"JAMA"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1081\/CLT-120026525","volume":"41","author":"GR Bond","year":"2003","unstructured":"Bond GR, Steele PE, Uges DR: Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine. J Toxicol Clin Toxicol. 2003, 41: 999-1002. 10.1081\/CLT-120026525.","journal-title":"J Toxicol Clin Toxicol"},{"key":"74_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1176\/ajp.2007.164.2.349","volume":"164","author":"PM Santos","year":"2007","unstructured":"Santos PM, L\u00f3pez-Garc\u00eda PN, J S, Fern\u00e1ndez AS, S\u00e1daba B, Vidal JP: False positive phencyclidine results caused by venlafaxine. Am J Psychiatry. 2007, 164: 349-10.1176\/appi.ajp.164.2.349.","journal-title":"Am J Psychiatry"},{"key":"74_CR16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/clinchem\/48.4.676","volume":"48","author":"SF Sena","year":"2002","unstructured":"Sena SF, Kazimi S, Wu AH: False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clin Chem. 2002, 48: 676-677.","journal-title":"Clin Chem"},{"key":"74_CR17","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1345\/aph.1G107","volume":"39","author":"EM Caravati","year":"2005","unstructured":"Caravati EM, Juenke JM, Crouch BI, Anderson KT: Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays. Ann Pharmacother. 2005, 39: 1446-1449. 10.1345\/aph.1G107.","journal-title":"Ann Pharmacother"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1081\/CLT-120019122","volume":"41","author":"RG Henrickson","year":"2003","unstructured":"Henrickson RG, Morocco AP: Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays. J Toxicol Clin Toxicol. 2003, 41: 105-108. 10.1081\/CLT-120019122.","journal-title":"J Toxicol Clin Toxicol"},{"key":"74_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1176\/ajp.157.1.148-a","volume":"157","author":"KL Sloan","year":"2000","unstructured":"Sloan KL, Haver VM, Saxon AJ: Quetiapine and false-positive urine drug testing for tricyclic antidepressants. Am J Psychiatry. 2000, 157: 148-149.","journal-title":"Am J Psychiatry"},{"key":"74_CR20","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1039\/b409813g","volume":"2","author":"A Bender","year":"2004","unstructured":"Bender A, Glen RC: Molecular similarity: a key technique in molecular informatics. Org Biomol Chem. 2004, 2: 3204-3218. 10.1039\/b409813g.","journal-title":"Org Biomol Chem"},{"key":"74_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/bst0310603","volume":"31","author":"P Willett","year":"2003","unstructured":"Willett P: Similarity-based approaches to virtual screening. Biochem Soc Trans. 2003, 31: 603-606. 10.1042\/BST0310603.","journal-title":"Biochem Soc Trans"},{"key":"74_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","volume":"152","author":"S Ekins","year":"2007","unstructured":"Ekins S, Mestres J, Testa B: In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol. 2007, 152: 21-37. 10.1038\/sj.bjp.0707306.","journal-title":"Br J Pharmacol"},{"key":"74_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/138920307781369427","volume":"8","author":"AS Reddy","year":"2007","unstructured":"Reddy AS, Pati SP, Kumar PP, Pradeep HN, Sastry GN: Virtual screening in drug discovery \u2013 a computational perspective. Curr Protein Pept Sci. 2007, 8: 329-351. 10.2174\/138920307781369427.","journal-title":"Curr Protein Pept Sci"},{"key":"74_CR24","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1039\/b409865j","volume":"2","author":"J Hert","year":"2004","unstructured":"Hert J, Willett P, Wilton DJ, Acklin P, Azzaoui K, Jacoby E, Schuffenhauer A: Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Org Biomol Chem. 2004, 2: 3256-3266. 10.1039\/b409865j.","journal-title":"Org Biomol Chem"},{"key":"74_CR25","volume-title":"Ther Drug Monit","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Siam MG, Iyer M, Ekins S: Molecular similarity methods for predicting cross-reactivity With therapeutic drug monitoring immunoassays. Ther Drug Monit. 2009,"},{"key":"74_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1373\/clinchem.2008.118638","volume":"55","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Siam MG, Iyer M, Pizon AF, Giannoutsos S, Ekins S: Chemoinformatic methods for predicting interference in drug of abuse\/toxicology immunoassays. Clin Chem . 2009, 55: 1203-1213.","journal-title":"Clin Chem"},{"key":"74_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nbt1228","volume":"24","author":"GV Paolini","year":"2006","unstructured":"Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL: Global mapping of pharmacological space. Nat Biotechnol. 2006, 24: 805-815. 10.1038\/nbt1228.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"74_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15563650801971390","volume":"47","author":"AF Pizon","year":"2009","unstructured":"Pizon AF, Schwartz AR, Shum LM, Rittenberger JC, Lower DR, Giannoutsos S, Virji MA, Krasowski MD: Toxicology laboratory analysis and human exposure to p-chloroaniline. Clin Toxicol (Phila). 2009, 47 (2): 132-136.","journal-title":"Clin Toxicol (Phila)"},{"key":"74_CR29","unstructured":"Red Book. 2008, Montvale, NJ: Thomson Healthcare"},{"key":"74_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2165\/00023210-200620030-00003","volume":"20","author":"K Wolff","year":"2006","unstructured":"Wolff K, Winstock AR: Ketamine: from medicine to misuse. CNS Drugs. 2006, 20: 199-218. 10.2165\/00023210-200620030-00003.","journal-title":"CNS Drugs"},{"key":"74_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/jat\/28.7.563","volume":"28","author":"JT Cody","year":"2004","unstructured":"Cody JT, Valtier S, Nelson SL: Amphetamine excretion profile following multidose adminstration of mixed salt amphetamine preparation. J Anal Toxicol. 2004, 28: 563-574.","journal-title":"J Anal Toxicol"},{"key":"74_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00007691-200412000-00013","volume":"26","author":"I Kim","year":"2004","unstructured":"Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA: Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit. 2004, 26: 664-672. 10.1097\/00007691-200412000-00013.","journal-title":"Ther Drug Monit"},{"key":"74_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jat\/30.8.545","volume":"30","author":"RH Liu","year":"2006","unstructured":"Liu RH, Liu H-C, Lin D-L: Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens. J Anal Toxicol. 2006, 30: 545-550.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"74_CR34","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1520\/JFS11796J","volume":"29","author":"B Levine","year":"1984","unstructured":"Levine B, Caplan YH, Dixon AM: A fatality involving phentermine. J Forensic Sci. 1984, 29 (4): 1242-1245.","journal-title":"J Forensic Sci"},{"key":"74_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM197204062861405","volume":"286","author":"RL Katz","year":"1972","unstructured":"Katz RL: Sedatives and tranquilizers. New Engl J Med. 1972, 286: 757-760.","journal-title":"New Engl J Med"},{"key":"74_CR36","first-page":"211","volume":"39","author":"RJ Bastiani","year":"1973","unstructured":"Bastiani RJ, Phillips RC, Schneider RS, Ullman EF: Homogenous immunochemical drug assays. Am J Med Technol. 1973, 39: 211-216.","journal-title":"Am J Med Technol"},{"key":"74_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(25)29578-7","volume":"186","author":"B Peskar","year":"1973","unstructured":"Peskar B, Spector S: Quantitative determination of diazepam in blood by immunoassay. J Pharmacol Exp Ther. 1973, 186: 167-172.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"74_CR38","first-page":"258","volume":"16","author":"J Kanto","year":"1978","unstructured":"Kanto J, Sellman R, Haataja M, Hurme P: Plasma and urine concentrations of diazepam and its metabolites in children, adults and in diazepam-intoxicated patients. Int J Clin Pharmacol Biopharm. 1978, 16 (6): 258-264.","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"74_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jps.2600630407","volume":"63","author":"SA Kaplan","year":"1974","unstructured":"Kaplan SA, Alexander K, Jack ML, Puglisi CV, de Silva JAF, Lee TL, Weinfeld RE: Pharmacokinetic profiles of clonazepam in dog and humans and flunitrazepam in dog. J Pharm Sci. 1974, 63: 527-532. 10.1002\/jps.2600630407.","journal-title":"J Pharm Sci"},{"key":"74_CR40","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00216-003-2050-7","volume":"376","author":"A Negrusz","year":"2003","unstructured":"Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PG: Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem. 2003, 376: 1198-1204. 10.1007\/s00216-003-2050-7.","journal-title":"Anal Bioanal Chem"},{"key":"74_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/cpt1977212222","volume":"21","author":"DJ Greenblatt","year":"1977","unstructured":"Greenblatt DJ, Joyce TH, Comer WH, Knowles JA, Shader RI, Kyriakopoulos AA, MacLaughlin DS, Ruelius HW: Clinical pharmacokinetics of lorazepam. II. Intramuscular injection. Clin Pharmacol Ther. 1977, 21: 222-230.","journal-title":"Clin Pharmacol Ther"},{"key":"74_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/cpt1976203329","volume":"20","author":"DJ Greenblatt","year":"1976","unstructured":"Greenblatt DJ, Schillings RT, Kyriakopoulos AA, Shader RI, Sisenwine SF, Knowles JA, Ruelius HW: Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam. Clin Pharmacol Ther. 1976, 20: 329-341.","journal-title":"Clin Pharmacol Ther"},{"key":"74_CR43","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/clinchem\/48.11.2047","volume":"48","author":"D Borrey","year":"2002","unstructured":"Borrey D, Meyer E, Duchateau L, Lambert W, Van Peteghem C, De Leenheer A: Enzymatic hydrolysis improves the sensitivity of Emit screening for urinary benzodiazepines. Clin Chem. 2002, 48: 2047-2049.","journal-title":"Clin Chem"},{"key":"74_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jat\/29.3.193","volume":"29","author":"KL Klette","year":"2005","unstructured":"Klette KL, Wiegand RF, Horn CK, Stout PR, Magluilo J: Urine benzodiazepine screening using Roche Online KIMS immunoassay with \u03b2-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry. J Anal Toxicol. 2005, 29: 193-200.","journal-title":"J Anal Toxicol"},{"key":"74_CR45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/jat\/31.8.462","volume":"31","author":"MA Huestis","year":"2007","unstructured":"Huestis MA, Darwin WD, Shimomura E, Lalani SA, Trinidad DV, Jenkins AJ, Cone EJ, Jacobs AJ, Smith ML, Paul BD: Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol. 2007, 31: 462-468.","journal-title":"J Anal Toxicol"},{"key":"74_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0376-8716(03)00200-X","volume":"72","author":"DS Harris","year":"2003","unstructured":"Harris DS, Everhart ET, Mendelson J, Jones RT: The pharmacology of cocaethylene administration in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003, 72: 169-182. 10.1016\/S0376-8716(03)00200-X.","journal-title":"Drug Alcohol Depend"},{"key":"74_CR47","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1345\/aph.1H451","volume":"41","author":"KW Chamberlin","year":"2007","unstructured":"Chamberlin KW, Cottle M, Neville R, Tan J: Oral oxymorphone for pain management. Ann Pharmacother. 2007, 41: 1144-1152. 10.1345\/aph.1H451.","journal-title":"Ann Pharmacother"},{"key":"74_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","volume":"81","author":"WM Compton","year":"2006","unstructured":"Compton WM, Volkow ND: Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81: 103-107. 10.1016\/j.drugalcdep.2005.05.009.","journal-title":"Drug Alcohol Depend"},{"key":"74_CR49","unstructured":"Mayo Medical Laboratories, Urine Opiates. [ http:\/\/www.mayomedicallaboratories.com\/test-catalog\/Clinical+and+Interpretive\/8473 ]"},{"key":"74_CR50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0090-9556(25)08048-1","volume":"11","author":"EJ Cone","year":"1983","unstructured":"Cone EJ, Darwin WD, Buchwald WF, Gorodetzky CW: Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog. Drug Metab Dispos. 1983, 11: 446-450.","journal-title":"Drug Metab Dispos"},{"key":"74_CR51","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","volume":"33","author":"R P\u00f6yhi\u00e4","year":"1992","unstructured":"P\u00f6yhi\u00e4 R, Sepp\u00e4la T, Olkkola KT, Kalso E: The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol. 1992, 33: 617-621.","journal-title":"Br J Clin Pharmacol"},{"key":"74_CR52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/jat\/25.7.504","volume":"25","author":"ML Smith","year":"2001","unstructured":"Smith ML, Shimomura ET, Summers J, Paul BD, Jenkins AJ, Darwin WD, Cone EJ: Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol. 2001, 25: 504-514.","journal-title":"J Anal Toxicol"},{"key":"74_CR53","first-page":"325","volume":"104","author":"DL Thombs","year":"1989","unstructured":"Thombs DL: A review of PCP abuse trends and perceptions. Public Health Rep. 1989, 104: 325-328.","journal-title":"Public Health Rep"},{"key":"74_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0378-4347(00)80105-X","volume":"223","author":"EJ Cone","year":"1981","unstructured":"Cone EJ, Buchwald W, Yousnefnejad D: Simultaneous determination of phencyclidine and monohydroxylated metabolites in urine of man by gas chromatography-mass fragmentography with methane chemical ionization. J Chromatogr. 1981, 223: 331-339. 10.1016\/S0378-4347(00)80105-X.","journal-title":"J Chromatogr"},{"key":"74_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/000992280504400702","volume":"44","author":"RH Schwartz","year":"2005","unstructured":"Schwartz RH: Adolescent abuse of dextromethorphan. Clin Pediatr (Phila). 2005, 44: 565-568.","journal-title":"Clin Pediatr (Phila)"},{"key":"74_CR56","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archpedi.160.12.1217","volume":"160","author":"JK Bryner","year":"2006","unstructured":"Bryner JK, Wang UK, Hui JW, Bedodo M, MacDougall C, Anderson IB: Dextromethorphan abuse in adolescence: an increasing trend: 1999\u20132004. Arch Pediatr Adolesc Med. 2006, 160: 1217-1222. 10.1001\/archpedi.160.12.1217.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"74_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/01.ftd.0000246767.12872.5b","volume":"29","author":"A Dasgupta","year":"2007","unstructured":"Dasgupta A, Wells A, Datta P: False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine. Ther Drug Monit. 2007, 29: 134-139. 10.1097\/01.ftd.0000246767.12872.5b.","journal-title":"Ther Drug Monit"},{"key":"74_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jat\/14.5.273","volume":"14","author":"GM Meenan","year":"1990","unstructured":"Meenan GM, Barlotta S, Lehrer M: Urinary tricyclic antidepressant screening: comparison of results obtained with Abbott FPIA reagents and Syva EIA reagents. J Anal Toxicol. 1990, 14: 273-276.","journal-title":"J Anal Toxicol"},{"key":"74_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jat\/31.5.270","volume":"31","author":"SE Melanson","year":"2007","unstructured":"Melanson SE, Lewandrowski EL, Griggs DA, Flood JG: Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis. J Anal Toxicol. 2007, 31: 270-275.","journal-title":"J Anal Toxicol"},{"key":"74_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/jat\/14.4.219","volume":"14","author":"P Nebinger","year":"1990","unstructured":"Nebinger P, Koel M: Specificity data of the tricyclic antidepressants assay by fluorescent polarization immunoassay. J Anal Toxicol. 1990, 14: 219-221.","journal-title":"J Anal Toxicol"},{"key":"74_CR61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0735-6757(94)90266-6","volume":"12","author":"JG Schwartz","year":"1994","unstructured":"Schwartz JG, Hurd IL, Carnahan JJ: Determination of tricyclic antidepressants for ED analysis. Am J Emerg Med. 1994, 12: 513-516. 10.1016\/0735-6757(94)90266-6.","journal-title":"Am J Emerg Med"},{"key":"74_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G: Major depressive disorder. New Engl J Med. 2008, 358: 55-68. 10.1056\/NEJMra073096.","journal-title":"New Engl J Med"},{"key":"74_CR63","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1592\/phco.27.11.1571","volume":"27","author":"MW Jann","year":"2007","unstructured":"Jann MW, Slade JH: Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy. 2007, 27: 1571-1587. 10.1592\/phco.27.11.1571.","journal-title":"Pharmacotherapy"},{"key":"74_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00002508-200103000-00015","volume":"17","author":"JH Lofland","year":"2001","unstructured":"Lofland JH, Szarlej D, Buttaro T, Shermock S, Jalalil S: Cyclobenzaprine hydrochloride is a commonly prescribed centrally acting muscle relaxant, which is structurally similar to tricyclic antidepressants (TCAs), and differs from amitriptyline by only one double bond. Clin J Pain. 2001, 17: 103-104. 10.1097\/00002508-200103000-00015.","journal-title":"Clin J Pain"},{"key":"74_CR65","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1345\/aph.1E632","volume":"39","author":"NM Van Hoey","year":"2005","unstructured":"Van Hoey NM: Effect of cyclobenzaprine on tricyclic antidepressant assays. Ann Pharmacother. 2005, 39: 1314-1317. 10.1345\/aph.1E632.","journal-title":"Ann Pharmacother"},{"key":"74_CR66","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1176\/appi.ajp.162.9.1755-a","volume":"162","author":"MZ Hussain","year":"2005","unstructured":"Hussain MZ, Waheed W, Hussain S: Intravenous quetiapine abuse. Am J Psychiatry. 2005, 162: 1755-1756. 10.1176\/appi.ajp.162.9.1755-a.","journal-title":"Am J Psychiatry"},{"key":"74_CR67","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/SMJ.0b013e3180f62d53","volume":"100","author":"RR Reeves","year":"2007","unstructured":"Reeves RR, Brister JC: Additional evidence of the abuse potential of quetiapine. South Med J. 2007, 100: 834-836.","journal-title":"South Med J"},{"key":"74_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1176\/ajp.2007.164.1.173a","volume":"164","author":"BM Waters","year":"2007","unstructured":"Waters BM, Joshi KG: Intravenous quetiapine-cocaine use (\"Q-ball\"). Am J Psychiatry. 2007, 164: 173-174. 10.1176\/appi.ajp.164.1.173-a.","journal-title":"Am J Psychiatry"},{"key":"74_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jat\/29.7.675","volume":"29","author":"RC Backer","year":"2005","unstructured":"Backer RC, Monforte JR, Poklis A: Evaluation of the DRI\u00ae Oxycodone immunoassay for the detection of oxycodone in urine. J Anal Toxicol. 2005, 29: 675-677.","journal-title":"J Anal Toxicol"},{"key":"74_CR70","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jat\/23.6.549","volume":"23","author":"AD Fraser","year":"1999","unstructured":"Fraser AD, Worth D: Experience with a urine opiate screening and confirmation cutoff of 2000 ng\/mL. J Anal Toxicol. 1999, 23: 549-551.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"74_CR71","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1520\/JFS11041J","volume":"30","author":"J M\u00f8rland","year":"1985","unstructured":"M\u00f8rland J, Bugge A, Skuterud B, Steen A, Wethe GH, Kjeldsen T: Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. J Forensic Sci. 1985, 30 (4): 997-1002.","journal-title":"J Forensic Sci"},{"key":"74_CR72","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00216-007-1330-z","volume":"388","author":"F Arduini","year":"2007","unstructured":"Arduini F, Amine A, Moscone D, Ricci F, Palleschi G: Fast, sensitive and cost-effective detection of nerve agents in the gas phase using a portable instrument and an electrochemical biosensor. Anal Bioanal Chem. 2007, 388: 1049-1057. 10.1007\/s00216-007-1330-z.","journal-title":"Anal Bioanal Chem"},{"key":"74_CR73","doi-asserted-by":"publisher","first-page":"28576","DOI":"10.1074\/jbc.273.44.28576","volume":"273","author":"K Lim","year":"1998","unstructured":"Lim K, Owens SM, Arnold L, Sacchettini JC, Linthicum DS: Crystal structure of monoclonal 6B5 Fab complexed with phencyclidine. J Biol Chem. 1998, 273: 28576-28582. 10.1074\/jbc.273.44.28576.","journal-title":"J Biol Chem"},{"key":"74_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/jmbi.2001.4839","volume":"311","author":"NA Larsen","year":"2001","unstructured":"Larsen NA, Zhou B, Heine A, Wirsching P, Janda KD, Wilson IA: Crystal structure of a cocaine-binding antibody. J Mol Biol. 2001, 311: 9-15. 10.1006\/jmbi.2001.4839.","journal-title":"J Mol Biol"},{"key":"74_CR75","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jmb.2005.03.080","volume":"349","author":"E Pozharski","year":"2005","unstructured":"Pozharski E, Moulin A, Hewagama A, Shanafelt AB, Petsko GA, Ringe D: Diversity in hapten recognition: structural study of an anti-cocaine M82G2. J Mol Biol. 2005, 349: 570-582. 10.1016\/j.jmb.2005.03.080.","journal-title":"J Mol Biol"},{"key":"74_CR76","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jmb.2003.12.084","volume":"337","author":"E Pozharski","year":"2004","unstructured":"Pozharski E, Wilson MA, Hewagama A, Shanafelt AB, Petsko G, Ringe D: Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine. J Mol Biol. 2004, 337: 691-697. 10.1016\/j.jmb.2003.12.084.","journal-title":"J Mol Biol"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-227X-9-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-9-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-9-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-227X-9-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T06:16:08Z","timestamp":1739081768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcemergmed.biomedcentral.com\/articles\/10.1186\/1471-227X-9-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1186\/1471-227x-9-5","relation":{},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]},"article-number":"5"}}